Delivery Order SPE2DB20D2104-SPE2DB23FT37T
- Not listed
- The Defense Logistics Agency (DLA) awarded a $13,138.72 firm-fixed-price delivery order (SPE2DB22D3016|SPE2DB24FAZJ5) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg naloxone hydrochloride nasal spray. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award is for the delivery of 4,559,406,389 units of Naloxone HCl 4 mg Nasal Spray to the Defense Logistics Agency (DLA). The award, valued at $3,854.16, was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a period of performance through December 19, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,960,168 units of Naloxone HCl 4 mg nasal spray. The firm-fixed-price contract, valued at $3,088.40, has a completion date of June 21, 2024. AmerisourceBergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a wide range of medical products, including prescription medications,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,369.72 fixed-price delivery order is for the supply of 4,566,326,707 units of Naloxone HCL 4 mg Nasal Spray, with a completion date of November 5, 2024. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order valued at $9,878.74 for the supply of 4,559,255,614 units of 4 mg naloxone hydrochloride nasal spray. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 5, 2022. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,431.79 for the supply of 4,559,121,146 units of 4 mg naloxone hydrochloride nasal spray. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,289.81 firm fixed-price delivery order is for 4,567,538,673 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, with a performance period ending on March 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Naloxone HCL 4 mg nasal spray with a ceiling value of $1,100.49. This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made on...
- This federal contract award, valued at $1,838.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,999,320 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. This delivery order contract has a firm fixed-price pricing type and an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp also...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,566,401 units of Naloxone HCl 4 mg Nasal Spray. The firm-fixed-price delivery order, valued at $2,157.33, has a completion date of November 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT37TDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,011.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,832,406 units of Naloxone HCL 4 mg nasal spray. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order, with a performance period through May 5, 2023, demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 5/4/23 |